We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · October 25, 2022

Effect of Pioglitazone on Epicardial Fat and Diastolic Function in Patients With Type 2 Diabetes

Diabetes, Obesity & Metabolism

 

Additional Info

Diabetes, Obesity & Metabolism
Pioglitazone Reduces Epicardial Fat and Improves Diastolic Function in Patients with Type 2 Diabetes
Diabetes Obes Metab 2022 Oct 07;[EPub Ahead of Print], AJ Moody, M Molina-Wilkins, GD Clarke, A Merovci, C Solis-Herrera, E Cersosimo, RJ Chilton, P Iozzo, A Gastaldelli, M Abdul-Ghani, RA DeFronzo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading